Centerline Biomedical Inc, a provider of an IOPS platform that is a navigation system for minimally invasive surgery, disclosed on Monday the election of Phil Rackliffe MBA as its chief executive officer (CEO).

Effective immediately, Rackliffe will lead the company in launching its recently FDA cleared Intra-Operative Positioning System (IOPS) with augmented reality 3D guidance, navigation and control (3D-GNC).

The company stated that the IOPS platform is a navigation system for minimally invasive surgery, leveraging anatomical mapping and electromagnetic tracking to provide three-dimensional color visualisation and real time guidance during endovascular interventions without the continuous use of X-ray radiation typical of the current standard of care.

According to the company, Rackliffe has launched more than 25 products to help improve patients' lives and changing clinical practice in the medical device and pharmaceutical industry globally as well as led significant mergers and acquisitions across the globe.